First-in-Human clinical study of TDURA (99mTc-Duramycin) in patients with advanced colorectal cancer (CRC)
Latest Information Update: 17 May 2021
At a glance
- Drugs Tc-99m duramycin (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions; First in man; Therapeutic Use
- 17 May 2021 New trial record
- 11 May 2021 According to a Molecular Targeting Technologies media release, the company and University of Antwerp announced that the European Federal Agency for Medicines and Health Products (FAMHP) has approved a Clinical Trial Application for this study.